Otsuka's Taiho pays $400M for Swiss partner to 'turbocharge' 3 ADCs to clinic

Otsuka's Taiho pays $400M for Swiss partner to 'turbocharge' 3 ADCs to clinic

Submitted by admin on March 17, 2025 - 11:09am
Source: 
Fierce Biotech
News Tags: 
Otsuka
Taiho Pharmaceutical
M&A
Araris Biotech
Headline: 
Otsuka's Taiho pays $400M for Swiss partner to 'turbocharge' 3 ADCs to clinic
snippet: 

Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug conjugate (ADC) linker platform.

Do Not Allow Advertisers to Use My Personal information